Outpatient treatment of decompensated heart failure: A systematic review and study level meta‐analysis

Author:

Bahar Jameela1,Rahman Amna1,Wong Grace W.Y.2,Sankaranarayanan Rajiv34,Ahmed Fozia Z.56,Taylor Rebecca1,Fuat Ahmet7,Squire Iain8,Cleland John G.F.9,Lip Gregory Y.H.1011,Gamble James H.P.12,Masudi Sundas1,Joseph Prince Josiah S.1,Wong Kenneth Y.K.14

Affiliation:

1. Department of Cardiology, Lancashire Cardiac Centre Blackpool UK

2. Lancashire Cardiac Centre Patient Public Involvement Group, Lancashire Cardiac Centre Blackpool Teaching Hospitals NHS Foundation Trust Blackpool UK

3. Liverpool University Hospitals NHS Foundation Trust Liverpool UK

4. Liverpool Centre for Cardiovascular Science University of Liverpool Liverpool UK

5. Keele University, Keele Cardiovascular Research Group Keele UK

6. Department of Cardiology Manchester University Hospitals NHS Foundation Trust Manchester UK

7. Durham University UK

8. NIHR Cardiovascular Research Centre Glenfield Hospital Leicester UK

9. British Heart Foundation Centre of Research Excellence, School of Cardiovascular and Metabolic Health University of Glasgow Glasgow UK

10. Liverpool Centre for Cardiovascular Science at University of Liverpool Liverpool John Moores University and Liverpool Heart and Chest Hospital Liverpool UK

11. Department of Clinical Medicine Aalborg University Aalborg Denmark

12. Oxford Heart Centre John Radcliffe Hospital Oxford UK

Abstract

AbstractPatients with acutely decompensated heart failure (ADHF) are usually admitted to hospital for management. There is growing interest in delivering intravenous (IV) diuretic therapy at home, in the community or at hospital day‐care units; the safety and effectiveness of outpatient‐based management (OPM) for ADHF has not been established. We conducted a systematic literature review and meta‐analysis to investigate the short‐term safety and effectiveness of OPM compared with inpatient management (IPM) of ADHF. Pre‐specified endpoints were 30 day mortality and 30 day hospitalization. The meta‐analysis was conducted using RevMan 5.4 software. Twenty‐nine studies of OPM were identified, including 7683 patients. Only five studies directly compared OPM (n = 1303) with IPM (n = 2047), including three observational studies, and two randomized controlled trials (RCTs). The other 24 studies only stated OPM outcomes. For the five studies comparing IPM versus OPM, patients were generally aged >75 years and of similar age for each strategy, with a similar proportion of men (56%). In a study‐level, aggregate analysis, 30 day all‐cause mortality was 9.3% (121/1303) for OPM, compared with 15.6% (320/2047) for IPM [OR 0.29 (95% CI 0.09, 0.93) P = 0.04]. Four studies reported 30 day all‐cause hospitalization; 22.0% for IPM versus 16.8% for OPM [OR 0.73 (95% CI 0.61, 0.89), P = 0.001]. In the two RCTs, we found no difference in 30 day mortality or hospitalization. In observational studies, OPM of ADHF is associated with lower 30 day hospitalization and lower 30 day mortality; such differences were not observed in two small, single‐centre RCTs. A substantial, multicentre RCT is required to confirm the safety and effectiveness of OPM for ADHF.

Funder

Research and Innovation Division, Manchester University NHS Foundation Trust

Publisher

Wiley

Reference27 articles.

1. British Heart Foundation Heart and Circulatory Disease Statistics 2022. [Internet].2022. Available from:https://www.bhf.org.uk/‐/media/files/research/heart‐statistics/bhf‐statistics‐compendium‐2022.pdf?rev=79c10677e14141ee886970ac9808f1db&hash=79A256DC5330081D89E5D5124E1F60EC[last accessed on 29th November 2022].

2. National Institute for Cardiovascular Outcomes Research.National Heart Failure Audit 2022 summary report (2020/2021 data) [Internet].2020. Available from:https://www.nicor.org.uk/wp‐content/uploads/2022/06/NHFA‐DOC‐2022‐FINAL.pdf[last accessed on 21st September 2022].

3. How to prescribe loop diuretics in oedema

4. How to prescribe loop diuretics in oedema

5. Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3